What we're reading, October 27, 2015: a much-improved Healthcare.gov website, report says drug prices rose at a much slower rate in 2015, and USPSTF recommends glucose testing in asymptomatic adults who are overweight or obese.
Newly Remodeled HealthCare.gov Site More User Friendly
The new website, reports The New York Times, has worked as the government promised, during the third open enrollment season. A new feature this year is a cost calculator that helps would-be enrollees compare different health plans based on their estimate of low, medium, of high use of medical services in 2016, though it does not let users sort plans based on total costs.
Read more here: http://nyti.ms/1k73ejo.
2015 Sees a More Gradual Slope to Prescription Drug Prices
A new analysis by the healthcare technology firm Truveris, reports that prescription drug prices rose 9.1% through September 30, 2015, for all medicines, compared with 10.9% seen in 2014. This information is based on the company’s analysis of claims data that included more than 300 million prescription payments to US pharmacies. The claims data does not account for drug rebates, coupons, or copay cards.
Read more here: http://bit.ly/208u4bH.
USPSTF Recommends Screening for Glucose and T2DM in Overweight and Obese Adults
The U.S. Preventive Services Task Force (USPSTF), as part of cardiovascular risk assessment in obese and overweight adults 40 to 70 years of age, has recommended screening for blood glucose levels. Additionally, the USPSTF recommendation urges physicians to refer patients with abnormal glucose levels to behavior counseling to ensure a healthy diet and incorporating physical activity in their daily life.
Read the paper published in the Annals of Internal Medicine here: http://bit.ly/1N38TCJ.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More